Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Iatrogenic botulism after botulinum toxin type A: Five cases
View through CrossRef
Botulinum toxin A (BTX-A) is frequently used for spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine and cosmetic purposes. Therapeutic use is generally safe. It is important to consider the risk of iatrogenic botulism, especially in high dose approved or with unapproved formulations and indications. Five patients with iatrogenic botulism were described. All patient developed systemic symtomps of Botulism following botulinum toxin injection for various reason. Clinical presentatiton, treatment and outcome were explained in this report.
Conclusion: Based on the case series reported, we would like to emphasize the important of adhering to recommended dose of approved formulations approved or unapproved indication of BTX-A.
ASEAN Neurological Association
Title: Iatrogenic botulism after botulinum toxin type A: Five cases
Description:
Botulinum toxin A (BTX-A) is frequently used for spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine and cosmetic purposes.
Therapeutic use is generally safe.
It is important to consider the risk of iatrogenic botulism, especially in high dose approved or with unapproved formulations and indications.
Five patients with iatrogenic botulism were described.
All patient developed systemic symtomps of Botulism following botulinum toxin injection for various reason.
Clinical presentatiton, treatment and outcome were explained in this report.
Conclusion: Based on the case series reported, we would like to emphasize the important of adhering to recommended dose of approved formulations approved or unapproved indication of BTX-A.
Related Results
Outbreak of type A foodborne botulism
Outbreak of type A foodborne botulism
The purpose — to study the clinical and epidemiological features of the outbreak of type A foodborne botulism in Kazan.
Material and methods. We analyzed 22 case histories of pati...
Antiarrhythmic properties of Botulinum toxin A: in vitro studies on human and rat cardiomyocytes
Antiarrhythmic properties of Botulinum toxin A: in vitro studies on human and rat cardiomyocytes
Abstract
Botulinum toxin A is a well-known neurotransmitter inhibitor with a wide range of applications in modern medicine. In recent years, botulinum toxin preparations ha...
Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy
Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy
Introduction This article reviews the mechanism of action of botulinum toxin and provides an overview of its use in hand disorders relevant to hand therapy such as hyperhidrosis, s...
Public perception and knowledge toward the non-cosmetic use of botulinum toxin in dermatology practices
Public perception and knowledge toward the non-cosmetic use of botulinum toxin in dermatology practices
Background: While botulinum toxin is widely known for its cosmetic applications, its therapeutic potential in dermatology remains under-recognized by the general public. This study...
Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism
Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism
A 7-week-old boy presented with symptoms and signs characteristic of infant botulism, and the diagnosis was confirmed by the detection of Clostridium botulinum type A organisms and...
Botulinum toxin A and chronic back pain: a randomized, double‐blinded study. (Walter Reed Army Medical Center, Washington, DC) Neurology. 2001;56:1290–1293.
Botulinum toxin A and chronic back pain: a randomized, double‐blinded study. (Walter Reed Army Medical Center, Washington, DC) Neurology. 2001;56:1290–1293.
This study investigated the efficacy of botulinum toxin A in chronic low back pain and associated disabilities. Thirty‐one consecutive patients with chronic low back pain who met t...
Correction of Iatrogenic Facial Asymmetry Caused by Botulinum Toxin Using Contralateral Injection: A Case Report
Correction of Iatrogenic Facial Asymmetry Caused by Botulinum Toxin Using Contralateral Injection: A Case Report
Abstract
Facial symmetry is a key determinant of aesthetic harmony and psychosocial well-being. Iatrogenic asymmetry is a recognized complication of botulinum tox...
Ophthalmic adverse events following facial injections of botulinum toxin A: A systemic literature review
Ophthalmic adverse events following facial injections of botulinum toxin A: A systemic literature review
AbstractBackgroundOver the years, botulinum toxin has found its place as a neuromuscular blocking agent in numerous medical fields. Since the approval of botulinum toxin by the FDA...